| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697669 | Cancer Treatment Reviews | 2017 | 27 Pages |
Abstract
Several new efficient therapeutic options are now available in prostate cancer management and should be evaluated against a chemo-hormonal combination therapy. Other trials are warranted to establish the role of docetaxel in earlier stages of the disease, the combination with the new hormonal therapies as well as the best management options after docetaxel.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gwenaëlle Gravis, François Audenet, Jacques Irani, Marc-Olivier Timsit, Philippe Barthelemy, Philippe Beuzeboc, Aude Fléchon, Claude Linassier, Stéphane Oudard, Xavier Rebillard, Pierre Richaud, Morgan Rouprêt, Antoine Thiery Vuillemin,